Lv1
90 积分 2022-03-22 加入
In Vivo CD19 CAR T-Cell Therapy for Refractory Systemic Lupus Erythematosus
1个月前
已完结
CD19 CAR T-Cell Therapy for Autoimmune Hemolytic Anemia
1个月前
已完结
Allogeneic CD19-targeting T cells for treatment-refractory systemic lupus erythematosus: a phase 1 tria
1个月前
已完结
Co-infusion of CD19-targeting and BCMA-targeting CAR-T cells for treatment-refractory systemic lupus erythematosus: a phase 1 trial
1个月前
已完结
Distinct in vivo dynamics of donor-derived stem cell memory CAR T cells post-allogeneic HSCT relapse
2个月前
已完结
T cell lymphomas: cancers of aberrant immune synapse signalling
2个月前
已完结
The 10 commandments of immunoregulation in lymphoma
3个月前
已关闭
Phase I first-in-human dose escalation study of the oral casein kinase 1α and cyclin dependent kinase 7/9 inhibitor BTX A51 in advanced MDS and AML
3个月前
已完结
Phase 1 study of CD19 CAR T-cell therapy harboring a fully human scFv in CAR-naïve adult patients with B-ALL
3个月前
已完结
In vivo generation of anti-BCMA CAR-T cells in relapsed or refractory multiple myeloma: a phase 1 study
3个月前
已完结
皖公网安备34019202002308
